AGENO, WALTER
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.437
EU - Europa 2.224
NA - Nord America 2.041
SA - Sud America 1.330
AF - Africa 905
OC - Oceania 97
Continente sconosciuto - Info sul continente non disponibili 34
Totale 10.068
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.483
HK - Hong Kong 1.088
BR - Brasile 941
PL - Polonia 653
CN - Cina 569
SG - Singapore 466
IT - Italia 260
VN - Vietnam 224
NL - Olanda 168
DE - Germania 135
KR - Corea 114
AR - Argentina 85
MX - Messico 61
TR - Turchia 60
RU - Federazione Russa 59
FI - Finlandia 58
FR - Francia 57
SE - Svezia 57
IN - India 55
CO - Colombia 51
CL - Cile 46
GB - Regno Unito 46
IQ - Iraq 44
ID - Indonesia 41
UY - Uruguay 39
GT - Guatemala 38
LB - Libano 38
AT - Austria 37
BA - Bosnia-Erzegovina 36
JO - Giordania 35
KE - Kenya 35
ZA - Sudafrica 34
CH - Svizzera 33
CZ - Repubblica Ceca 33
EC - Ecuador 33
HN - Honduras 33
JM - Giamaica 33
PK - Pakistan 33
RO - Romania 33
AL - Albania 32
CI - Costa d'Avorio 32
IE - Irlanda 32
EG - Egitto 31
LC - Santa Lucia 31
LV - Lettonia 31
UZ - Uzbekistan 31
AZ - Azerbaigian 30
DK - Danimarca 30
MA - Marocco 30
PR - Porto Rico 30
PY - Paraguay 30
SA - Arabia Saudita 30
VE - Venezuela 30
AE - Emirati Arabi Uniti 29
BO - Bolivia 29
CM - Camerun 29
DO - Repubblica Dominicana 29
IL - Israele 29
KZ - Kazakistan 29
MN - Mongolia 29
RS - Serbia 29
BD - Bangladesh 28
BE - Belgio 28
ET - Etiopia 28
KH - Cambogia 28
LA - Repubblica Popolare Democratica del Laos 28
MY - Malesia 28
NI - Nicaragua 28
PA - Panama 28
TT - Trinidad e Tobago 28
AM - Armenia 27
BZ - Belize 27
GH - Ghana 27
HT - Haiti 27
KG - Kirghizistan 27
LY - Libia 27
SK - Slovacchia (Repubblica Slovacca) 27
SN - Senegal 27
UG - Uganda 27
GE - Georgia 26
JP - Giappone 26
DZ - Algeria 25
PE - Perù 25
PS - Palestinian Territory 25
UA - Ucraina 25
BB - Barbados 24
BF - Burkina Faso 24
CA - Canada 24
CG - Congo 24
CV - Capo Verde 24
GM - Gambi 24
GR - Grecia 24
IR - Iran 24
MD - Moldavia 24
MW - Malawi 24
PT - Portogallo 24
AU - Australia 23
CY - Cipro 23
ES - Italia 23
HU - Ungheria 23
Totale 9.009
Salva come PNG Salva come JPEG
Città #
Hong Kong 1.062
Bytom 617
Singapore 379
Hefei 266
Ashburn 251
Fairfield 184
Beijing 118
Chandler 100
Ho Chi Minh City 95
Seoul 89
Munich 75
Woodbridge 75
Cambridge 70
Seattle 69
São Paulo 59
Houston 56
Wilmington 42
Ann Arbor 40
Chicago 39
Hanoi 35
Amman 33
Padova 33
Montevideo 32
Abidjan 29
Castries 29
Ulan Bator 29
Baku 28
Dakar 27
Kampala 27
Managua 27
Mexico City 27
Phnom Penh 27
Tashkent 27
Turku 27
Nairobi 26
Santa Clara 26
Kingston 25
Rio de Janeiro 25
Accra 24
Bishkek 24
Brasília 24
Los Angeles 24
Panama City 24
Riga 24
Vienna 24
Istanbul 23
Vientiane 23
Bamako 22
Dushanbe 22
Guatemala City 22
Lusaka 22
Yerevan 22
Luanda 21
Milan 21
San Diego 21
Boardman 20
Bridgetown 20
Kingstown 20
Rome 20
Conakry 19
Libreville 19
Nassau 19
Praia 19
Tirana 19
Zurich 19
Addis Ababa 18
Baghdad 18
Auckland 17
Banjul 17
Belgrade 17
Cayenne 17
Curitiba 17
Dublin 17
Harare 17
Kigali 17
Podgorica 17
Tbilisi 17
Tripoli 17
Andorra la Vella 16
Beirut 16
Bogotá 16
Douala 16
Düsseldorf 16
Havana 16
Helsinki 16
Luxembourg 16
Noumea 16
Salt Lake City 16
Tallinn 16
Fort Liberté 15
Lima 15
Ouagadougou 15
Port Moresby 15
Ribeirão Preto 15
Sanaa 15
Windhoek 15
Cotonou 14
Dar es Salaam 14
Djibouti 14
Lilongwe 14
Totale 5.366
Salva come PNG Salva come JPEG
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 230
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: the Multicenter Italian CORIST Study 204
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 171
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 161
The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism 152
Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism 145
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 143
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 133
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 130
Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysis. 112
Long-term outcomes of patients with cerebral vein thrombosis: A multicenter study 112
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 106
Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs 84
D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study 73
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 68
Inappropriate Underdosing of Direct Oral Anticoagulants in Atrial Fibrillation Patients: Results from the START2-AF Registry 57
Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: Clinical characteristics, antibody profiles and estimate of the risk of recurrence 55
Description of the clinical and radiological characteristics of pulmonary embolism in COVID-19 vs non–COVID-19 patients: a multicentric cross-sectional study over a 24-month perspective 53
D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results 52
Can the Charlson comorbidity index help to guide DOAC dosing in patients with atrial fibrillation and improve the efficacy and safety of treatment? A subanalysis of the MAS study 51
Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome 51
Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register 49
Rates of venous thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital hemophilia A or B: a systematic review 49
Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis 48
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 48
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism 46
Anticoagulation in Patients with Isolated Distal Deep Vein Thrombosis: Bringing the Puzzle Together 46
Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants 46
Measuring the crowding of emergency departments: an assessment of the NEDOCS in Lombardy, Italy, and the development of a new objective indicator based on the waiting time for the first clinical assessment 46
ANMCO Position Paper: Long-term follow-up of patients with pulmonary thromboembolism 43
Direct Oral Anticoagulants for Pulmonary Embolism 41
ANMCO Position paper: Recommendations for the follow-up of patients with pulmonary thromboembolism 41
Aktuelles zu Inzidenz, Risikofaktoren und Behandlung von venösen Thrombosen an ungewöhnlichen Stellen 41
PROPOSAL FOR THE INCLUSION OF LOW MOLECULAR WEIGHT HEPARINS FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN HOSPITALIZED PATIENTS IN THE WHO MODEL LIST OF ESSENTIAL MEDICINES 40
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment 40
Hypoalbuminaemia and heart failure: A practical review of current evidence 39
Cardiac power output is associated with cardiovascular related mortality in the ICU in post-cardiac arrest patients 39
Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function 38
Applying EBM in haematological practice 37
Anticoagulant treatment for pediatric splanchnic vein thrombosis: a systematic review and meta-analysis 37
Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer 37
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry 37
Reperfusion therapies in patients with acute ischaemic stroke and atrial fibrillation: data on safety and effectiveness from a multi-centre cohort study 37
Ultrasound elastography is useful to distinguish acute and chronic deep vein thrombosis 37
Catheter-related deep vein thrombosis: Where are we at and where are we going? Updates and ongoing unmet clinical needs 36
Factor XI/XIa inhibitors for splanchnic vein thrombosis associated with liver cirrhosis: Is there any potential role? 36
Survival and Quality of Life after Early Discharge in Low-Risk Pulmonary Embolism 36
Pharmacotherapeutic management of venous thromboembolism during pregnancy and cesarean section 35
Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE 35
Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE study 35
How to treat isolated distal deep vein thrombosis 35
Investigational drugs for ischemic stroke: what’s in the clinical development pipeline for acute phase and prevention? 35
In vitro effects of Apixaban on 5 different cancer cell lines 35
Oral anticoagulant therapy in patients with mechanical heart valve and intracranial haemorrhage. A systematic review 34
Systematic review: neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularization 34
The effect of DOAC-Stop® on several oral and parenteral anticoagulants 34
Management and Outcomes of Isolated Distal Deep Vein Thromboses: A Questionable Trend toward Long-Lasting Anticoagulation Treatment. Results from the START-Register 34
Incidence of chronic thromboembolic pulmonary hypertention after a first episode of pulmonary embolism 33
The Link Between Venous and Arterial Thrombosis: Is There a Role for Endothelial Dysfunction? 33
Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study 32
Guidelines and guidance: what is the path forward for the ISTH? 32
The metabolic syndrome and the risk of venous thrombosis: A case-control study 32
Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study 31
Diagnosis and management of venous thromboembolism: results of a questionnaire on current clinical practice 31
A Practical Clinical Approach to Navigate Pulmonary Embolism Management: A Primer and Narrative Review of the Evolving Landscape 31
Treatment of Superficial Vein Thrombosis: Recent Advances, Unmet Needs and Future Directions 31
Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism: a prospective cohort study 31
Long-term left ventricular thrombosis resolution in patients receiving vitamin k antagonists: a multicenter observational study 31
Coming soon to a pharmacy near you? FXI and FXII inhibitors to prevent or treat thromboembolism 31
Prognostic role of neutrophils to lymphocytes ratio in patients with acute pulmonary embolism: a systematic review and meta-analysis of the literature 31
Sex-related characteristics of cerebral vein thrombosis: A secondary analysis of a multicenter international cohort study 31
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy 30
The Clinical Impact of the Pulmonary Embolism Severity Index on the Length of Hospital Stay of Patients with Pulmonary Embolism: A Randomized Controlled Trial 30
Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: Randomised controlled trial 30
Current diagnostic and therapeutic approaches for peripheral arterial disease in Italy: a survey among vascular specialists of the Italian society of angiology and vascular medicine (SIAPAV) and general practitioners of the Italian federation of general practitioners (FIMMG) 30
Sex-related differences in non-ischemic myocardial injury in the emergency department: A real-world perspective 30
Common Practice in the Treatment of Superficial Vein Thrombosis Involving the Sapheno-Femoral Junction: Results from a National Survey of the Italian Society of Angiology and Vascular Medicine (SIAPAV) 30
Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry 30
Splanchnic vein thrombosis (2003−2022): a Swiss nationwide epidemiological study 30
Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials 30
Chronobiologic Aspects of Venous Thromboembolism 29
Risk of Coronary Artery Disease in Patients with Liver Cirrhosis: A Systematic Review and Meta-analysis 29
Risk of Bleeding in Liver Cirrhosis Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-analysis 29
Novel horizons in anticoagulation: the emerging role of factor XI inhibitors across different settings 29
How to manage splanchnic vein thrombosis in patients with liver disease 29
Algorithm for rapid exclusion of clinically relevant plasma levels of DOACs in patients using the DOAC Dipstick. An expert consensus paper 29
Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study 29
More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study 29
Timing of anticoagulation for the management of portal vein thrombosis in liver cirrhosis 29
SOA XIX: Lipid-lowering drugs and haemostasis 29
The legacy of Edwards and Steptoe and the windy roads of Assisted Reproduction: where do we stand with Venous Thromboembolism? 28
Six-week low-molecular-weight heparin versus 12-week warfarin for calf deep vein thrombosis: A randomized, prospective, open-label study 28
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs 28
The role of thrombolytic therapy in pulmonary embolism 27
The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2 27
Safety and efficacy of anticoagulant treatment in patients with ovarian vein thrombosis: a systematic review and meta-analysis of observational studies 27
Risk Factors for Intracerebral Hemorrhage in Patients with Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention 27
Incidence of symptomatic and asymptomatic chronic pulmonary hypertension in patients with a previous episode of pulmonary embolism: a prospective cohort study 27
Outpatient treatment of symptomatic pulmonary embolism. A systematic review 27
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis 27
Totale 5.033
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.509
article - articoli 26.785
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 80
patent - brevetti 0
selected - selezionate 0
volume - volumi 157
Totale 54.531
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021208 0 0 55 5 1 4 1 21 36 20 21 44
2021/2022323 35 4 59 26 31 15 12 24 40 9 18 50
2022/2023172 35 26 3 20 21 16 2 18 12 1 18 0
2023/2024152 3 12 13 10 11 29 13 36 6 2 13 4
2024/20253.936 7 47 52 20 42 31 28 35 56 643 1.140 1.835
2025/20265.558 697 1.966 2.895 0 0 0 0 0 0 0 0 0
Totale 10.592